Skip to main content

Table 2 Treatment response by age groups of the 48 enrolled patients

From: Poor treatment responses were related to poor outcomes in pediatric B cell acute lymphoblastic leukemia with KMT2A rearrangements

Treat respond

Infant group (n = 18)

Non infant group (n = 30)

Fisher test

P = 

dexamethasone induction (n = 48)

 Negative

6

14

 

0.5461

 Positive

12

16

 DGR

11

18

 

 > 0.9999

 DPR

7

12

 

BM status at TP1a(n = 47)

 M1

16

28

 

 > 0.9999

 M2 or M3

1

2

 

FCM-MRD level at TP1a (n = 47)

  < 0.01%

6

18

 

0.1351

  ≥ 0.01%

11

12

 

  < 1%

12

19

 

0.7526

  ≥ 1%

5

11

 

PCR-MRD level at TP1a (n = 47)

 Negative

6

10

 

 > 0.9999

 Positive

11

20

  

BM status at TP2a(n = 45)

 CR

12

28

 

0.1073

 Not CR

3

1

  

FCM-MRD level at TP2a (n = 45)

  < 0.01%

6

21

 

0.0526

  ≥ 0.01%

9

8

  

PCR-MRD level at TP2a (n = 45)

 Negative

7

17

 

0.5213

 Positive

8

11

  

Treat related mortality (n = 48)

 Yes

3

1

 

0.1415

 no

15

29

  
  1. a for survival patients